Xiaoming LI > Han Kun Law Offices > Beijing, China > Lawyer Profile

Han Kun Law Offices
9/F, OFFICE TOWER C1, ORIENTAL PLAZA
NO. 1 EAST CHANG AN AVE.
BEIJING 100738
China

Lawyer Rankings

China > Banking and finance: PRC firms

Han Kun Law Offices stands out in the area of asset finance, with a strong aircraft and shipping leasing practice. The group also regularly handles syndicated and bilateral loans, securitisations and cross-border lending. The department is led by Xiaoming Li and includes aviation finance experts Shu Wang and Zhu Jun ; financial services specialist TieCheng Yang, whose experience includes RMB internationalisation, bond issuances, securities and insurance; and Jun Wan, who has developed a niche in fintech, blockchain and crypto-currencies. In 2018, the group was joined by counsel Yi Ding from Baker McKenzie FenXun and Huhuan Li from Zhong Lun Law Firm.

China > Regulatory/compliance: PRC firms

Han Kun Law Offices advises multinational and foreign invested enterprises on a range of regulatory compliance issues including assisting with internal audits and investigations. The team is particularly active in handling anti-bribery, data protection and M&A-related compliance issues in the pharmaceutical industry. The team advised a Chinese subsidiary of a multinational company in an investigation against an employee who was suspected of infringing the client’s trade secrets, and acted for a pharmaceutical company in investigating internal corruption-related allegations against the employees of its Chinese subsidiary. David TangXiaoming Li and Wei Huang are the main contacts, as is Min Zhu who has ‘a deep understanding of the medical field and has unique insights into the dynamics and trends in the compliance space‘.

China > Healthcare and life sciences: PRC firms

Han Kun Law Offices excels in representing major funds in their big-ticket investments in China. Recent instructions also feature compliance, competition, IP and financing transactions. Chaoying LiYijun Chao Ying Yang and Wei Li handled a steady stream of financing and IPO mandates, Min Zhu advised a Chinese pharmaceutical company in its commercialisation and distribution arrangement and represented a pharmaceutical company in a trade secrets infringement dispute, and Chen Ma and Xiaoming Li acted for a multinational pharmaceutical company in investigating internal corruption-related allegations against the employees of its Chinese subsidiary.